AI 본문요약

엑셀 다운로드 AI-Helper

참고문헌 (71)

1. Ai, L., Li, Y., Zhou, L., Yao, W., Zhang, H., Hu, Z., Han,？J., Wang, W., Wu, J., Xu, P., Wang, R., Li, Z., Li, Z.,？Wei, C., Liang, J., Chen, H., Yang, Z., Guo, M., Huang,？Z., Wang, X., Zhang, Z., Xiang, W., Sun, D., Xu, L.,？Huang, M., Lv, B., Peng, P., Zhang, S., Ji, X., Luo, H.,？Chen, N., Chen, J., Lan, K. and Hu, Y. 2023. Lyophilized？mRNA-lipid nanoparticle vaccines with long-term stability？and high antigenicity against SARS-CoV-2. Cell Discov. 9, 9.？ 

2. Allen, T. M. and Cullis, P. R. 2004. Drug delivery systems: entering the mainstream. Science 303, 1818-1822.？ 

   상세보기

3. Anderluzzi, G., Lou, G., Gallorini, S., Brazzoli, M., Johnson, R., O'Hagan, D. T., Baudner, B. C. and Perrie, Y.？2020. Investigating the impact of delivery system design on the efficacy of self-amplifying RNA vaccines. Vaccines？(Basel) 8, 212.？ 

4. Anderson, B. R., Muramatsu, H., Nallagatla, S. R., Bevilacqua, P. C., Sansing, L. H., Weissman, D. and Kariko, K. 2010. Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation. Nucleic？Acids Res. 38, 5884-5892.？ 

   상세보기

5. Arevalo, C. P., Bolton, M. J., Sage, V. L., Ye, N., Furey,？C., Muramatsu, H., Alameh, M. -G., Pardi, N., Drapeau,？E. M., Parkhouse, K., Garretson, T., Morris, J. S., Moncla,？L. H., Tam, Y. K., Fan, S. H. Y., Lakdawala, S. S., Drew,？W. and Hensley, S. E. 2022. A multivalent nucleoside-modified mRNA vaccine against all known influenza virus？subtypes. Science 378, 899-904.？ 

   상세보기

6. Bahl, K., Senn, J. J., Yuzhakov, O., Bulychev, A., Brito,？L. A., Hassett, K. J., Laska, M. E., Smith, M., Almarsson,？O., Thompson, J., Ribeiro, A. M., Watson, M., Zaks, T.？and Ciaramella, G. 2017 Preclinical and clinical demonstration of immunogenicity by mRNA vaccines against？H10N8 and H7N9 Influenza Viruses. Mol. Ther. 25, 1316-1327.？ 

   상세보기

7. Benner, S., Jacob, F. and Meselson, M. 1961. An unstable？intermediate carrying information from genes to ribosomes？for protein synthesis. Nature 190, 576-581.？ 

   상세보기

8. Biju, V. 2014. Chemical modifications and bioconjugate？reactions of nanomaterials for sensing, imaging, drug delivery and therapy. Chem. Soc. Rev. 43, 744-764.？ 

   상세보기

9. Bloom, K., van den Berg, F. and Arbuthnot, P. 2021. Self-amplifying RNA vaccines for infectious diseases. Gene？Ther. 28, 117-129. 

   상세보기

10. Brundage, S. C. and Fitzpatrick, A. N. 2006. Hepatitis A.？Am. Fam. Physician 73, 2162-2168.？ 

    상세보기

11. Chen, S. C., Xu, C. T., Chang, C. F., Chao, T. Y., Lin,？C. C., Fu, P. W. and Yu, C. H. 2023. Optimization of？5'UTR to evade SARS-CoV-2 Nonstructural protein 1-directed inhibition of protein synthesis in cells. Appl. Microbiol. Biotechnol. 107, 2451-2468.？ 

12. Chen, T., Ding, Z., Lan, J. and Wong, G. 2023. Advances？and perspectives in the development of vaccines against？highly pathogenic bunyaviruses. Front. Cell Infect. Microbiol. 13, 1174030.？ 

    상세보기

13. Cheng, F., Wang, Y., Bai, Y., Liang, Z., Mao, Q., Liu,？D., Wu, X. and Xu, M. 2023. Research advances on the？stability of mRNA vaccines. Viruses 15, 668？ 

    상세보기

14. Christensen, D. 2016. Vaccine adjuvants: why and how.？Hum. Vaccin. Immunother. 12, 2709-2711.？ 

    상세보기

15. Conry, R. M., LoBuglio, A. F., Wright, M., Sumerel, L.,？Pike, M. J., Johanning, F., Benjamin, R., Lu, D. and Curiel,？D. T. 1995. Characterization of a messenger RNA polynucleotide vaccine vector. Cancer Res. 55, 1397-1400.？ 

    상세보기

16. Corbett, K. S., Edwards, D. K., Leist, S. R., Abiona, O.？M., Boyoglu-Barnum, S., Gillespie, R. A., Himansu, S.,？Schafer, A., Ziwawo, C. T., DiPiazza, A. T., Dinnon, K.？H., Elbashir, S. M., Shaw, C. A., Woods, A., Fritch. E.？J., Martinez, D. R., Bock, K. W., Minai, M., Nagata, B.？M., Hutchinson, G. B., Wu, K., Henry, C., Bahl, K.,？Garcia-Dominguez, D., Ma, L., Renzi, I., Kong, W. P.,？Schmidt, S. D., Wang, L., Zhang, Y., Phung, E., Chang,？L. A., Loomis, R. J., Altaras, N. E., Narayanan, E., Metkar,？M., Presnyak, V., Liu, C., Louder, M. K., Shi, W., Leung,？K., Yang, E. S., West, A., Gully, K. L., Stevens, L. J.,？Wang, N., Wrapp, D., Doria-Rose, N. A., Stewart-Jones,？G., Bennett, H., Alvarado, G. S., Nason, M. C., Ruckwardt, T. J., McLellan, J. S., Denison, M. R., Chappell,？J. D., Moore, I. N., Morabito, K. M., Mascola, J. R., Baric,？R. S., Carfi, A. and Graham, B. S. 2020. SARS-CoV-2？mRNA vaccine design enabled by prototype pathogen？preparedness. Nature 586, 567-571.？ 

17. Dimitriadis, G. J. 1978. Translation of rabbit globin mRNA？introduced by liposomes into mouse lymphocytes. Nature？274, 923-924.？ 

    상세보기

18. Erasmus, J. H., Khandhar, A. P., O'Connor, M. A., Walls,？A. C., Emily, A. H., Murapa, P., Archer, J., Leventhal,？S., Fuller, J. T, Lewis, T. B., Draves, K. E., Randall, S.,？Guerriero, K. A., Duthie, M. S., Carter, D., Reed, S. G.,？Hawman. D. W., Feldmann, H., Gale, M. Jr., Veesler, D.,？Berglund, P. and Fuller, D. H. 2020. An alphavirus-derived replicon RNA vaccine induces SARS-CoV-2？neutralizing antibody and T cell responses in mice and？nonhuman primates. Sci. Transl. Med. 12, eabc9396.？ 

    상세보기

19. Fang, E., Liu, X., Li, M., Zhang, Z., Song, L., Zhu, B.,？Wu, X., Liu, J., Zhao, D. and Li, Y. 2022. Advances in？COVID-19 mRNA vaccine development. Signal. Transduct.？Target Ther. 7, 94.？ 

20. Fischer, M., Lindsey, N., Staples, J. E. and Hills, S. 2010.？Japanese encephalitis vaccines: recommendations of the？Advisory committee on immunization practices (ACIP).？MMWR Recomm. Rep. 59, 1-27.？ 

    상세보기

21. Gergen, J. and Petsch, B. 2022. mRNA-based vaccines and？mode of action. Curr. Top Microbiol. Immunol. 440, 1-30.？ 

22. Griffin, D. E. and Metcalf, T. 2011. Clearance of virus？infection from the CNS. Curr. Opin. Virol. 1, 216-221.？ 

    상세보기

23. Hajj, K. A. and Whitehead, K. A. 2017. Tools for translation: non-viral materials for therapeutic mRNA delivery.？Nat. Rev. Mater. 2, 17056.？ 

    상세보기

24. He, C., Yang, J., Hong, W., Chen, Z., Peng, D., Lei, H.,？Alu, A., He, X., Bi, Z., Jiang, X., Jia, G., Yang, Y., Zhou,？Y., Yu, W., Tang, C., Huang, Q., Yang, M., Li, B., Li,？J., Wang, J., Que, H., Chen, L., Ren, W., Wan, D., Li,？J., Wang, W., Shen, G., Zhao, Z., Yang, L., Yang, J.,？Wang, Z., Su, Z., Wei, Y., Cen, X., Tanaka, Y., Song, X.,？Lu, S., Peng, X., Lu, G. and Wei, X. 2022. A self-assembled trimeric protein vaccine induces protective immunity against Omicron variant. Nat. Commun. 13, 5459.？ 

    상세보기

25. Heitmann, J. S., Bilich, T., Tandler, C., Nelde, A.,？Maringer, Y., Marconato, M., Reusch, J., Jager, S., Denk,？M., Richter, M., Anton, L., Weber, L. M., Roerden, M.,？Bauer, J., Rieth, J., Wacker, M., Horber, S., Peter, A.,？Meisner, C., Fischer, I., Loffler, M. W., Karbach, J., Jager, E., Klein, R., Rammensee, H. G., Salih, H. R. and Walz,？J. S. 2022. A COVID-19 peptide vaccine for the induction？of SARS-CoV-2 T cell immunity. Nature 601, 617-622.？ 

26. Holmgren, J. and Czerkinsky, C. 2005. Mucosal immunity？and vaccines. Nat. Med. 11, S45-53.？ 

    상세보기

27. Houser, K. V., Chen, G. L., Carter, C., Crank, M. C.,？Nguyen, T. A., Burgos Florez, M. C., Berkowitz, N. M.,？Mendoza, F., Hendel, C. S., Gordon, I. J., Coates, E. E.,？Vazquez, S., Stein, J., Case, C. L., Lawlor, H., Carlton,？K., Gaudinski, M. R., Strom, L., Hofstetter, A. R., Liang,？C. J., Narpala, S., Hatcher, C., Gillespie, R. A., Creanga,？A., Kanekiyo, M., Raab, J. E., Andrews, S. F., Zhang, Y.,？Yang, E. S., Wang, L., Leung, K., Kong, W. P., Freyn,？A. W., Nachbagauer, R., Palese, P., Bailer, R. T.,？McDermott, A. B., Koup, R. A., Gall, J. G., Arnold, F.,？Mascola, J. R., Graham, B. S. and Ledgerwood, J. E. 2022.？Safety and immunogenicity of a ferritin nanoparticle H2？influenza vaccine in healthy adults: A phase 1 trial. Nat.？Med. 28, 383-391.？ 

28. Jackson, N. A. C., Kester, K. E., Casimiro, D., Gurunathan,？S. and DeRosa, F. 2020. The promise of mRNA vaccines: a biotech and industrial perspective. Npj Vaccines 5, 3-8.？ 

29. Kariko, K., Muramatsu, H., Welsh, F. A., Ludwig, J.,？Kato, H., Akira, S. and Weissman, D. 2008. Incorporation？of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability. Mol. Ther. 16, 1833-1840.？ 

    상세보기

30. Karunakaran, B., Gupta, R., Patel, P., Salave, S., Sharma,？A., Desai, D., Benival, D. and Kommineni, N. 2023.？Emerging trends in lipid-based vaccine delivery: a special？focus on developmental strategies, fabrication methods,？and applications. Vaccines (Basel) 11, 661.？ 

    상세보기

31. Kelvin, A. A. and Falzarano, D. 2022. The influenza universe in an mRNA vaccine. Science 378, 827-828.？ 

    상세보기

32. Kew, O., Morris-Glasgow, V., Landaverde, M., Burns, C.,？Shaw, J., Garib, Z., Andre, J., Blackman, E., Freeman,？C. J., Jorba, J., Sutter, R., Tambini, G., Venczel, L.,？Pedreira, C., Laender, F., Shimizu, H., Yoneyama, T.,？Miyamura, T., van Der Avoort, H., Oberste, M. S.,？Kilpatrick, D., Cochi, S., Pallansch, M. and de Quadros,？C. 2002. Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus.？Science 296, 356-359.？ 

    상세보기

33. Kis, Z., Kontoravdi, C., Dey, A. K., Shattock, R. and Shah,？N. 2020. Rapid development and deployment of high-volume vaccines for pandemic response. J. Adv. Manuf. Process. 2, e10060.？ 

34. Kowalski, P. S., Rudra, A., Miao, L. and Anderson, D.？G. 2019. Delivering the messenger: advances in technologies for therapeutic mRNA delivery. Mol. Ther. 27, 710-728.？ 

    상세보기

35. Krammer, F. 2020. SARS-CoV-2 vaccines in development.？Nature 586, 516-527.？ 

36. Larson, H. J. 2018. The state of vaccine confidence. Lancet？392, 2244-2246.？ 

37. Lazarus, J. V., Ratzan, S. C., Palayew, A., Gostin, L. O.,？Larson, H. J., Rabin, K., Kimball, S. and El-Mohandes,？A. 2020. A global survey of potential acceptance of a COVID-19 vaccine. Nat. Med. 27, 225-228.？ 

38. Lo, M. K., Spengler, J. R., Welch, S. R., Harmon, J. R.,？Coleman-McCray, J. D., Scholte, F. E. M., Shrivastava-Ranjan, P., Montgomery, J. M., Nichol, S. T., Weissman,？D. and Spiropoulou, C. F. 2020. Evaluation of a single-dose nucleoside-modified messenger RNA vaccine encoding hendra virus-soluble glycoprotein against lethal nipah virus challenge in syrian hamsters. J. Infect. Dis. 221, S493-S498.？ 

    상세보기

39. Lu, R., Zhao, X., Li, J., Niu, P., Yang, B., Wu, H., Wang,？W., Song, H., Huang, B., Zhu, N., Bi, Y., Ma, X., Zhan,？F., Wang, L., Hu, T., Zhou, H., Hu, Z., Zhou, W., Zhao,？L., Chen, J., Meng, Y., Wang, J., Lin, Y., Yuan, J., Xie,？Z., Ma, J., Liu, W. J., Wang, D., Xu, W., Holmes, E. C.,？Gao, G. F., Wu, G., Chen, W., Shi, W. and Tan, W. 2022.？Genomic characterisation and epidemiology of 2019 novel？coronavirus: implications for virus origins and receptor？binding. Lancet 395, 565-574.？ 

40. MaHam, A., Tang, Z., Wu, H., Wang, J. and Lin, Y. 2009.？Protein-based nanomedicine platforms for drug delivery.？Small 5, 1706-1721.？ 

    상세보기

41. Mahapatro, A. and Singh, D. K. 2011. Biodegradable nanoparticles are excellent vehicle for site directed in-vivo delivery of drugs and vaccines. J. Nanobiotechnology 9, 55.？ 

    상세보기

42. Martinon, F., Krishnan, S., Lenzen, G., Magne, R., Gomard,？E., Guillet, J. G., Levy, J. P. and Meulien, P. 1993. Induction of virus-specific cytotoxic T lymphocytes in vivo by liposome-entrapped mRNA. Eur. J. Immunol. 23, 1719-1722.？ 

    상세보기

43. Meyer, M., Huang, E., Yuzhakov, O., Ramanathan, P.,？Ciaramella, G. and Bukreyev, A. 2018. Modified mRNA-based vaccines elicit robust immune responses and protect？guinea pigs from ebola virus disease. J. Infect. Dis. 217, 451-455.？ 

    상세보기

44. Mohsen, M. O. and Bachmann, M. F. 2022. Virus-like？particle vaccinology, from bench to bedside. Cell Mol.？Immunol. 19, 993-1011.？ 

45. Moon, J. J., Suh, H., Polhemus, M. E., Ockenhouse, C.？F., Yadava, A. and Irvine, D. J. 2012. Antigen-displaying？lipid-enveloped PLGA nanoparticles as delivery agents for a Plasmodium vivax malaria vaccine. PLoS One 7, e31472.？ 

    상세보기

46. Qian, C., Liu, X., Xu, Q., Wang, Z., Chen, J., Li, T., Zheng,？Q., Yu, H., Gu, Y., Li, S. and Xia, N. 2020. Recent progress on the versatility of virus-like particles. Vaccines？(Basel) 8, 139.？ 

47. Moradi Vahdat, M., Hemmati, F., Ghorbani, A., Rutkowska, D., Afsharifar, A., Eskandari, M. H., Rezaei, N. and？Niazi, A. 2021. Hepatitis B core-based virus-like particles: a platform for vaccine development in plants. Biotechnol.？Rep. 29, e00605.？ 

    상세보기

48. Palma, E., Pasqua, A., Gagliardi, A., Britti, D., Fresta, M.？and Cosco, D. 2018. Antileishmanial activity of amphotericin B-loaded-PLGA nanoparticles: an overview. Materials？11, E1167.？ 

    상세보기

49. Pardi, N., Hogan, M. J., Porter, F. W. and Weissman, D. 2018.mRNA vaccines - a new era in vaccinology. Nat.？Rev. Drug Discov. 17, 261-279.？ 

50. Pardi, N., Hogan, M. J. and Weissman, D. 2020. Recent？advances in mRNA vaccine technology. Curr. Opin. Immunol. 65, 14-20.？ 

    상세보기

51. Pizza, M., Pecetta, S. and Rappuoli, R. 2021. Vaccines？2020: The era of the digital vaccine is here. Sci. Transl.？Med. 13, eabm3249.？ 

    상세보기

52. Plowrigh, R. K., Parrish, C. R., McCallum, H., Hudson,？P. J, Ko, A. I., Graham, A. L. and Lloyd-Smith, J. O. 2017.？Pathways to zoonotic spillover. Nat. Rev. Microbiol. 15, 502-510.？ 

    상세보기

53. Richner, J. M., Himansu, S., Dowd, K. A., Butler, S. L.,？Salazar, V., Fox, J. M., Julander, J. G., Tang, W. W.,？Shresta, S., Pierson, T. C., Ciaramella, G. and Diamond,？M. S. 2017. Modified mRNA vaccines protect against zika？virus infection. Cell 169, 176.？ 

    상세보기

54. Rosa, S. S., Prazeres, M. F., Azevedo, A. M. and Marques,？M. P. C. 2021. Marques mRNA vaccines manufacturing:？Challenges and bottlenecks. Vaccine 39, 2190-2200.？ 

55. Roth, C., Cantaert, T., Colas, C., Prot, M., Casademont, I., Levillayer, L., Thalmensi, J., Langlade-Demoyen, P.,？Gerke, C., Bahl, K., Ciaramella, G., Simon-Loriere, E. and？Sakuntabhai, A. 2019. A Modified mRNA Vaccine targeting immunodominant NS epitopes protects against dengue？virus infection in HLA class I transgenic mice. Front.？Immunol. 10, 1424.？ 

56. Schiller, J. and Lowy, D. 2018. Explanations for the high？potency of HPV prophylactic vaccines. Vaccine 36, 4768-4773.？ 

57. Shae, D., Postma, A. and Wilson, J. T. 2016. Vaccine delivery: where polymer chemistry meets immunology. Ther.？Deliv. 7, 193-196.？ 

    상세보기

58. Stacey, D. 1976. Microinjection studies of duck globin？messenger RNA translation in human and avian cells. Cell？9, 725-732.？ 

    상세보기

59. Sulczewski, F. B., Liszbinski, R. B., Romao, P. R. T. and？Rodrigues Junior, L. C. 2018. Nanoparticle vaccines？against viral infections. Arch. Virol. 163, 2313-2325.？ 

    상세보기

60. Uddin, M. N. and Roni, M. A. 2021. Challenges of Storage？and Stability of mRNA-Based COVID-19 Vaccines. Vaccines (Basel) 9, 1033.？ 

    상세보기

61. Vu, M. N., Kelly, H. G., Kent, S. J. and Wheatley, A.？K. 2021. Current and future nanoparticle vaccines for？COVID-19. eBioMedicine 74, 103699.？ 

    상세보기

62. Venkatesan, P. 2021. Preliminary phase 1 results from an HIV vaccine candidate trial. Lancet Microbe 2, e95.？ 

    상세보기

63. Venkatraman, S. S., Ma, L. L., Natarajan, J. V. and Chattopadhyay, S. 2010. Polymer-and liposome-based nanoparticles in targeted drug delivery. Front. Biosci. (Schol？Ed) 2, 801-814.？ 

    상세보기

64. Vicente, T., Mota, J. P. B., Peixoto, C., Alves, P. M. and？Carrondo, M. J. T. 2011. Rational design and optimization？of downstream processes of virus particles for biopharmaceutical applications: current advances. Biotechnol. Adv.？29, 869-878.？ 

    상세보기

65. Vogel, A. B., Lambert, L., Kinnear, E., Busse, D., Erbar,？S., Reuter, K. C., Wicke, L., Perkovic, M., Beissert, T.,？Haas, H., Reece, S. T., Sahin, U. and Tregoning, J. S.？2018. Self-amplifying RNA vaccines give equivalent protection against influenza to mRNA vaccines but at much？lower doses. Mol. Ther. 26, 446-455.？ 

    상세보기

66. Wang, Y. and Grainger, D. W. 2019. Lyophilized liposome-based parenteral drug development: reviewing？complex product design strategies and current regulatory？environments. Adv. Drug. Deliv. Rev. 151-152, 56-71.？ 

67. Williams, W. B., Wiehe, K., Saunders, K. O. and Haynes,？B. F. 2021. Strategies for induction of HIV-1 envelope-reactive broadly neutralizing antibodies. J. Int. AIDS Soc.？24, e25831.？ 

    상세보기

68. Wu, F., Zhao, S., Yu, B., Chen, Y. M., Wang, W., Song,？Z. G., Hu, Y., Tao, Z. W., Tian, J. H., Pei, Y. Y., Yuan,？M. L., Zhang, Y. L., Dai, F. H., Liu, Y., Wang, Q. M.,？Zheng, J. J., Xu, L., Holmes, E. C. and Zhang, Y. Z. 2020.？A new coronavirus associated with human respiratory disease in China. Nature 579, 265-269.？ 

69. Zeng, C., Zhang, C., Walker, P. G. and Dong, Y. 2022.？Formulation and delivery technologies for mRNA vaccines. Curr. Top Microbiol. Immunol. 440, 71-110.？ 

70. Zhou, P. and Shi, Z. L. 2021. SARS-CoV-2 spillover？events. Science 371, 120-122.？ 

    상세보기

71. Zhu, N., Zhang, D., Wang, W., Li, X., Yang B., Song,？J., Zhao, X., Huang, B., Shi, W., Lu, R., Niu, P., Zhan,？F., Ma, X., Wang, D, Xu, W., Wu, G., Gao, F. G. and？Tan, W. 2020. A Novel Coronavirus from patients with？pneumonia in China, 2019. N. Engl. J. Med. 382, 727-733.？ 

    상세보기